Comparative Tobacco Interventions for Individuals With Severe and Persisting Behavioral Health Disorders
THRRP
1 other identifier
observational
100
1 country
1
Brief Summary
The aim of this pilot intervention is to examine the acceptability of a harm reduction intervention approach to tobacco use for individuals with serious behavioral health disorders and its association with a decrease in smoking. The intervention uses a "dynamic" approach to patient choice, allowing participants the option to explore different strategies for harm reduction, while providing support from counselors in the process. Therefore, the investigators have chosen an observational study design in order to document and explore the acceptability and outcomes of the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 30, 2020
CompletedFirst Submitted
Initial submission to the registry
July 23, 2020
CompletedFirst Posted
Study publicly available on registry
August 24, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2023
CompletedSeptember 28, 2021
September 1, 2021
2.8 years
July 23, 2020
September 22, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Number of cigarettes smoked
Self-reported number of cigarettes smoked per day
Change in number of cigarettes smoked per day will be assessed using two time frames: 1) Baseline to 6 months post baseline; and 2) Post intervention which is change from baseline to 12 months post baseline.
Nicotine Dependence
Fagerström Test for Nicotine Dependence, a self-reported scale rated from 0-10, with \>=5 indicating dependence (Heatherton et al., 1991).
Change in nicotine dependence will be assessed using two time frames: 1) during the intervention, which is change from baseline to 6 months post baseline; and 2) after the intervention which is change from baseline to 12 months post baseline
Carbon Monoxide
Exhaled carbon monoxide level concentration reported in parts per million (ppm) using a breathalyzer assay
Change in carbon monoxide level will be assessed using two time frames: 1) during the intervention, which is change from baseline to 6 months post baseline; and 2) after the intervention which is change from baseline to 12 months post baseline
Salivary Tobacco Use
Salivary tobacco use level reported in nicotine metabolites (cotinine)
Change in salivary nicotine level will be assessed using two time frames: 1) during the intervention, which is change from baseline to 6 months post baseline; and 2) after the intervention which is change from baseline to 12 months post baseline
Secondary Outcomes (3)
Smoking Decisional Balance
Change in smoking decisional balance will be assessed using two time frames: 1) during the intervention, which is change from baseline to 6 months post baseline; and 2) after the intervention which is change from baseline to 12 months post baseline
Challenges to Smoking Behavior Change
Change in challenges to smoking behavior change will be assessed on two occasions: 1) during the intervention from baseline to 6 months post baseline; and 2) after the intervention which is change from baseline to 12 months post baseline.
Working Alliance Inventory
Change in working alliance quality will be assessed using two time frames: 1) during the intervention, which is change from baseline to 6 months post baseline; and 2) after the intervention which is change from baseline to 12 months post baseline.
Study Arms (5)
Cohort One
Subjects will be invited to participate in brief weekly in person or telehealth behavioral support with the objective of reducing their rate of combustible tobacco use. Subjects will also be offered the choice of various conventional nicotine replacement aids, snus, electronic cigarette, varenicline or bupropion.
Cohort Two
Subjects will be invited to participate in brief weekly in person or telehealth behavioral support with the objective of reducing their rate of combustible tobacco use. Subjects will also be offered the choice of various conventional nicotine replacement aids, snus, electronic cigarette, varenicline or bupropion.
Cohort Three
Subjects will be invited to participate in brief weekly in person or telehealth behavioral support with the objective of reducing their rate of combustible tobacco use. Subjects will also be offered the choice of various conventional nicotine replacement aids, snus, electronic cigarette, varenicline or bupropion.
Cohort Four
Subjects will be invited to participate in brief weekly in person or telehealth behavioral support with the objective of reducing their rate of combustible tobacco use. Subjects will also be offered the choice of various conventional nicotine replacement aids, snus, electronic cigarette, varenicline or bupropion.
Cohort Five
Subjects will be invited to participate in brief weekly in person or telehealth behavioral support with the objective of reducing their rate of combustible tobacco use. Subjects will also be offered the choice of various conventional nicotine replacement aids, snus, electronic cigarette, varenicline or bupropion.
Interventions
Behavioral and pharmacological support to reduce combustible tobacco use.
Eligibility Criteria
Adult individuals who are or have been served by public systems related to a mental health or substance use disorder and are currently using combustible tobacco.
You may qualify if:
- Individuals who are formerly or currently being served by San Francisco Bay Area Public Health behavioral health providers. These will include individuals with psychotic, affective, anxiety, personality and substance use disorders.
- Individuals who are not currently enrolled in another formal tobacco intervention or research study.
- Are at least 21 years of age and able to speak English\*
- Who score in the "low to moderate dependence" range on the Fagerstrom Test of Nicotine Dependence
- Have used tobacco for at least two years
- Express willingness to participate at least weekly in the intervention strategy
- Express a desire to make some change in their tobacco use pattern
- Express some reason to change their tobacco use pattern
- Have the cognitive capacity to be able to sign a consent to participate in the research
- A concerted effort will be made to recruit bilingual Chinese and Spanish language staff
You may not qualify if:
- The individual does not currently smoke tobacco
- Individuals younger than 21 years of age at the time of enrollment
- Who score in the "low" range on the Fagerstrom Test of Nicotine Dependence
- Have used tobacco for less than two years;
- Express unwillingness to participate at least weekly in the intervention strategy
- Decline an interest in making some change in their tobacco use pattern
- Do not indicate the cognitive capacity to be able to sign a consent to participate in the research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rose Research Center, LLClead
- Foundation for a Smoke Free World INCcollaborator
Study Sites (1)
San Francisco Study Center
San Francisco, California, 94102, United States
Related Publications (12)
Dickerson F, Stallings CR, Origoni AE, Vaughan C, Khushalani S, Schroeder J, Yolken RH. Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999-2011. Psychiatr Serv. 2013 Jan;64(1):44-50. doi: 10.1176/appi.ps.201200143.
PMID: 23280457BACKGROUNDEvins AE, Cather C, Laffer A. Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices. Harv Rev Psychiatry. 2015 Mar-Apr;23(2):90-8. doi: 10.1097/HRP.0000000000000063.
PMID: 25747922BACKGROUNDGlasheen C, Hedden SL, Forman-Hoffman VL, Colpe LJ. Cigarette smoking behaviors among adults with serious mental illness in a nationally representative sample. Ann Epidemiol. 2014 Oct;24(10):776-80. doi: 10.1016/j.annepidem.2014.07.009. Epub 2014 Jul 30.
PMID: 25169683BACKGROUNDHartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018 May 31;5(5):CD000146. doi: 10.1002/14651858.CD000146.pub5.
PMID: 29852054BACKGROUNDJensen AB, Hounsgaard L. "I only smoke when I have nothing to do": a qualitative study on how smoking is part of everyday life in a Greenlandic village. Int J Circumpolar Health. 2013 Aug 5;72. doi: 10.3402/ijch.v72i0.21657. eCollection 2013.
PMID: 23967409BACKGROUNDLindson-Hawley N, Banting M, West R, Michie S, Shinkins B, Aveyard P. Gradual Versus Abrupt Smoking Cessation: A Randomized, Controlled Noninferiority Trial. Ann Intern Med. 2016 May 3;164(9):585-92. doi: 10.7326/M14-2805. Epub 2016 Mar 15.
PMID: 26975007BACKGROUNDLindson-Hawley N, Hartmann-Boyce J, Fanshawe TR, Begh R, Farley A, Lancaster T. Interventions to reduce harm from continued tobacco use. Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3.
PMID: 27734465BACKGROUNDRae J, Pettey D, Aubry T, Stol J. Factors affecting smoking cessation efforts of people with severe mental illness: a qualitative study. J Dual Diagn. 2015;11(1):42-9. doi: 10.1080/15504263.2014.992096.
PMID: 25491704BACKGROUNDSchroeder SA, Morris CD. Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems. Annu Rev Public Health. 2010;31:297-314 1p following 314. doi: 10.1146/annurev.publhealth.012809.103701.
PMID: 20001818BACKGROUNDStead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016 Mar 24;3(3):CD008286. doi: 10.1002/14651858.CD008286.pub3.
PMID: 27009521BACKGROUNDTwyman L, Bonevski B, Paul C, Bryant J. Perceived barriers to smoking cessation in selected vulnerable groups: a systematic review of the qualitative and quantitative literature. BMJ Open. 2014 Dec 22;4(12):e006414. doi: 10.1136/bmjopen-2014-006414.
PMID: 25534212BACKGROUNDUppal N, Shahab L, Britton J, Ratschen E. The forgotten smoker: a qualitative study of attitudes towards smoking, quitting, and tobacco control policies among continuing smokers. BMC Public Health. 2013 May 3;13:432. doi: 10.1186/1471-2458-13-432.
PMID: 23641875BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kevin McGirr, MS, MPH
San Francisco Study Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 23, 2020
First Posted
August 24, 2020
Study Start
January 30, 2020
Primary Completion
October 31, 2022
Study Completion
July 31, 2023
Last Updated
September 28, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share
There is currently no plan to share IPD.